269. 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群 ［臨床試験数：20，薬物数：26（DrugBank：10），標的遺伝子数：12，標的パスウェイ数：90］
Searched query = "Pyogenic arthritis", "Pyoderma gangrenosum", "Acne syndrome", "PAPA syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||NCT03311464||October 27, 2017||12/10/2017||A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan||A Phase 3 Multicenter, Open-Label, Single Arm Study of the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Subjects in Japan||Pyoderma Gangrenosum||Drug: adalimumab||AbbVie||NULL||Completed||18 Years||N/A||All||22||Phase 3||Japan|
|2||NCT00730717||May 2009||4/8/2008||Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum||Multi Center, Open Label Pilot Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum||Pyoderma Gangrenosum||Drug: Humira||Wright State University||Stanford University;Wake Forest School of Medicine||Withdrawn||18 Years||N/A||Both||20||Phase 2||United States|
|3||NCT00690846||July 2007||2/6/2008||Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum||A Multi-Center, Open Label Pilot Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum (HUM 04-37)||Pyoderma Gangrenosum||Drug: adalimumab||Wake Forest University Health Sciences||NULL||Withdrawn||18 Years||N/A||All||0||Phase 2||United States|